Aethlon Medical Inc (AEMD)
1.512
+0.03
(+2.16%)
USD |
NASDAQ |
Apr 23, 16:00
Aethlon Medical Cash from Financing (TTM): 1.242M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 1.242M |
September 30, 2023 | 1.063M |
June 30, 2023 | 9.373M |
March 31, 2023 | 8.915M |
December 31, 2022 | 8.907M |
September 30, 2022 | 8.895M |
June 30, 2022 | 0.5671M |
March 31, 2022 | 17.37M |
December 31, 2021 | 17.35M |
September 30, 2021 | 17.30M |
June 30, 2021 | 17.31M |
March 31, 2021 | 7.128M |
December 31, 2020 | 14.32M |
September 30, 2020 | 18.95M |
June 30, 2020 | 18.45M |
March 31, 2020 | 11.13M |
December 31, 2019 | 4.356M |
September 30, 2019 | 0.6316M |
June 30, 2019 | 1.093M |
March 31, 2019 | 1.147M |
December 31, 2018 | 3.129M |
September 30, 2018 | 7.777M |
June 30, 2018 | 9.451M |
March 31, 2018 | 9.350M |
December 31, 2017 | 8.866M |
Date | Value |
---|---|
September 30, 2017 | 4.246M |
June 30, 2017 | 2.824M |
March 31, 2017 | 2.958M |
December 31, 2016 | 1.060M |
September 30, 2016 | 0.214M |
June 30, 2016 | 0.0148M |
March 31, 2016 | 5.607M |
December 31, 2015 | 5.584M |
September 30, 2015 | 9.576M |
June 30, 2015 | 9.926M |
March 31, 2015 | 4.655M |
December 31, 2014 | 4.662M |
September 30, 2014 | 3.402M |
June 30, 2014 | 3.553M |
March 31, 2014 | 3.36M |
December 31, 2013 | 3.914M |
September 30, 2013 | 1.665M |
June 30, 2013 | 1.436M |
March 31, 2013 | 2.080M |
December 31, 2012 | 2.071M |
September 30, 2012 | 1.947M |
June 30, 2012 | 2.204M |
March 31, 2012 | 1.971M |
December 31, 2011 | 1.679M |
September 30, 2011 | 1.604M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.5671M
Minimum
Jun 2022
18.95M
Maximum
Sep 2020
9.703M
Average
8.915M
Median
Mar 2023
Cash from Financing (TTM) Benchmarks
Perspective Therapeutics Inc | 0.785M |
Retractable Technologies Inc | 0.9416M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |
Catheter Precision Inc | 8.386M |